SVP, Drug Discovery
Jean-Christophe Harmange, Pharm.D, Ph.D is Senior Vice President of Drug Discovery at Psivant. He brings more than 25 years of small molecule drug discovery spanning multiple therapeutic areas. At Psivant, Jean-Christophe is leading the identification, optimization and early development of drug candidates across our portfolio.
Before joining Psivant, Jean-Christophe built and lead several small molecule drug discovery organizations who successfully delivered multiple clinical candidates. Prior to his previous CSO role at Triana Biomedicines, he served as the SVP of Research at Goldfinch bio, Entrepreneur in Residence at Third Rock Ventures, and the Executive Director of drug discovery at Constellation Pharmaceuticals. He also held positions of increasing responsibility at Amgen, Eisai and Servier.
Jean-Christophe received his Pharm.D. and Ph.D. in organic chemistry from the Université Paris-Sud and completed his postdoctoral training at Harvard University in Professor Yoshito Kishi’s laboratory. Jean-Christophe is co-inventor on more than 30 issued U.S. patents and the author of numerous publications.